Search

everythinglearnresearchcommunity

for

Search:↓

A man developed skin issues from cancer medication, which improved with specific treatments.

2011 dermatology discussions highlighted stem cell hair treatments, new lichen planopilaris therapies, skin side effects from cancer drugs, emerging allergens, and the link between food allergies and skin issues.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Sorafenib may cause hair loss in a way similar to alopecia areata.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Minoxidil, propranolol, and furosemide effectively control severe hypertension, but may cause sodium retention.

Thuja orientalis hot water extract may help hair grow by starting the growth phase and improving hair follicle development.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Finasteride may cause kidney damage.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Nivolumab can cause hair loss as a rare side effect.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

A man with kidney tumors and lung cysts was diagnosed with Birt–Hogg–Dubé syndrome and treated successfully, with genetic testing confirming the diagnosis.